Literature DB >> 22267089

Multiparametric MRI maps for detection and grading of dominant prostate tumors.

Mehdi Moradi1, Septimiu E Salcudean, Silvia D Chang, Edward C Jones, Nicholas Buchan, Rowan G Casey, S Larry Goldenberg, Piotr Kozlowski.   

Abstract

PURPOSE: To develop an image-based technique capable of detection and grading of prostate cancer, which combines features extracted from multiparametric MRI into a single parameter map of cancer probability.
MATERIALS AND METHODS: A combination of features extracted from diffusion tensor MRI and dynamic contrast enhanced MRI was used to characterize biopsy samples from 29 patients. Support vector machines were used to separate the cancerous samples from normal biopsy samples and to compute a measure of cancer probability, presented in the form of a cancer colormap. The classification results were compared with the biopsy results and the classifier was tuned to provide the largest area under the receiver operating characteristic (ROC) curve. Based solely on the tuning of the classifier on the biopsy data, cancer colormaps were also created for whole-mount histopathology slices from four radical prostatectomy patients.
RESULTS: An area under ROC curve of 0.96 was obtained on the biopsy dataset and was validated by a "leave-one-patient-out" procedure. The proposed measure of cancer probability shows a positive correlation with Gleason score. The cancer colormaps created for the histopathology patients do display the dominant tumors. The colormap accuracy increases with measured tumor area and Gleason score.
CONCLUSION: Dynamic contrast enhanced imaging and diffusion tensor imaging, when used within the framework of supervised classification, can play a role in characterizing prostate cancer.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22267089      PMCID: PMC5478377          DOI: 10.1002/jmri.23540

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  33 in total

1.  3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1).

Authors:  B Nicolas Bloch; Neil M Rofsky; Ronaldo H Baroni; Robert P Marquis; Ivan Pedrosa; Robert E Lenkinski
Journal:  Acad Radiol       Date:  2004-08       Impact factor: 3.173

2.  Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T--quantitative correlation with biopsy.

Authors:  Piotr Kozlowski; Silvia D Chang; Ran Meng; Burkhard Mädler; Robert Bell; Edward C Jones; S Larry Goldenberg
Journal:  Magn Reson Imaging       Date:  2010-04-13       Impact factor: 2.546

3.  Diffusion imaging of the prostate at 3.0 tesla.

Authors:  Peter Gibbs; Martin D Pickles; Lindsay W Turnbull
Journal:  Invest Radiol       Date:  2006-02       Impact factor: 6.016

4.  Supervised and unsupervised methods for prostate cancer segmentation with multispectral MRI.

Authors:  Sedat Ozer; Deanna L Langer; Xin Liu; Masoom A Haider; Theodorus H van der Kwast; Andrew J Evans; Yongyi Yang; Miles N Wernick; Imam S Yetik
Journal:  Med Phys       Date:  2010-04       Impact factor: 4.071

Review 5.  Robotic radical prostatectomy in patients with high-risk disease: a review of short-term outcomes from a high-volume center.

Authors:  Gautam Jayram; Guarionex J Decastro; Michael C Large; Aria Razmaria; Gregory P Zagaja; Arieh L Shalhav; Charles B Brendler
Journal:  J Endourol       Date:  2011-01-15       Impact factor: 2.942

6.  Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience.

Authors:  David L Buckley; Caleb Roberts; Geoff J M Parker; John P Logue; Charles E Hutchinson
Journal:  Radiology       Date:  2004-10-21       Impact factor: 11.105

7.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging.

Authors:  Bashar Issa
Journal:  J Magn Reson Imaging       Date:  2002-08       Impact factor: 4.813

8.  Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue.

Authors:  Keyanoosh Hosseinzadeh; Samuel David Schwarz
Journal:  J Magn Reson Imaging       Date:  2004-10       Impact factor: 4.813

9.  Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tables.

Authors:  H Augustin; G A Fritz; T Ehammer; M Auprich; K Pummer
Journal:  Acta Radiol       Date:  2009-06       Impact factor: 1.990

10.  Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI.

Authors:  Geoff J M Parker; Caleb Roberts; Andrew Macdonald; Giovanni A Buonaccorsi; Sue Cheung; David L Buckley; Alan Jackson; Yvonne Watson; Karen Davies; Gordon C Jayson
Journal:  Magn Reson Med       Date:  2006-11       Impact factor: 4.668

View more
  11 in total

1.  A data-driven approach to prostate cancer detection from dynamic contrast enhanced MRI.

Authors:  Nandinee Fariah Haq; Piotr Kozlowski; Edward C Jones; Silvia D Chang; S Larry Goldenberg; Mehdi Moradi
Journal:  Comput Med Imaging Graph       Date:  2014-07-05       Impact factor: 4.790

2.  Automated prostate cancer detection using T2-weighted and high-b-value diffusion-weighted magnetic resonance imaging.

Authors:  Jin Tae Kwak; Sheng Xu; Bradford J Wood; Baris Turkbey; Peter L Choyke; Peter A Pinto; Shijun Wang; Ronald M Summers
Journal:  Med Phys       Date:  2015-05       Impact factor: 4.071

3.  Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.

Authors:  K Pinker; H Bickel; T H Helbich; S Gruber; P Dubsky; U Pluschnig; M Rudas; Z Bago-Horvath; M Weber; S Trattnig; W Bogner
Journal:  Eur Radiol       Date:  2013-03-16       Impact factor: 5.315

Review 4.  Interactive Feature Space Explorer© for multi-modal magnetic resonance imaging.

Authors:  Alpay Özcan; Barış Türkbey; Peter L Choyke; Oguz Akin; Ömer Aras; Seong K Mun
Journal:  Magn Reson Imaging       Date:  2015-04-11       Impact factor: 2.546

5.  Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images.

Authors:  Duc Fehr; Harini Veeraraghavan; Andreas Wibmer; Tatsuo Gondo; Kazuhiro Matsumoto; Herbert Alberto Vargas; Evis Sala; Hedvig Hricak; Joseph O Deasy
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

6.  Final Gleason score prediction using discriminant analysis and support vector machine based on preoperative multiparametric MR imaging of prostate cancer at 3T.

Authors:  Fusun Citak-Er; Metin Vural; Omer Acar; Tarik Esen; Aslihan Onay; Esin Ozturk-Isik
Journal:  Biomed Res Int       Date:  2014-12-02       Impact factor: 3.411

Review 7.  Computer aided-diagnosis of prostate cancer on multiparametric MRI: a technical review of current research.

Authors:  Shijun Wang; Karen Burtt; Baris Turkbey; Peter Choyke; Ronald M Summers
Journal:  Biomed Res Int       Date:  2014-12-01       Impact factor: 3.411

8.  Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer.

Authors:  Ahmad Chaddad; Michael J Kucharczyk; Tamim Niazi
Journal:  Cancers (Basel)       Date:  2018-07-28       Impact factor: 6.639

Review 9.  Artificial intelligence in cancer imaging: Clinical challenges and applications.

Authors:  Wenya Linda Bi; Ahmed Hosny; Matthew B Schabath; Maryellen L Giger; Nicolai J Birkbak; Alireza Mehrtash; Tavis Allison; Omar Arnaout; Christopher Abbosh; Ian F Dunn; Raymond H Mak; Rulla M Tamimi; Clare M Tempany; Charles Swanton; Udo Hoffmann; Lawrence H Schwartz; Robert J Gillies; Raymond Y Huang; Hugo J W L Aerts
Journal:  CA Cancer J Clin       Date:  2019-02-05       Impact factor: 508.702

10.  Computer aided detection in prostate cancer diagnostics: A promising alternative to biopsy? A retrospective study from 104 lesions with histological ground truth.

Authors:  Anika Thon; Ulf Teichgräber; Cornelia Tennstedt-Schenk; Stathis Hadjidemetriou; Sven Winzler; Ansgar Malich; Ismini Papageorgiou
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.